About
Paolo Cardone is a researcher at the Coma Science Group and a PhD candidate in the GIGA Doctoral School for Health Science at the University of Liège. His work focuses on complexity in brain networks and its relationship with consciousness, particularly in patients with disorders of consciousness (DoC). He employs advanced techniques such as TMS-EEG and neuroimaging to investigate how psychedelics like psilocybin and ketamine can enhance brain complexity and promote recovery in DoC patients.
Research Trends: Recent publications highlight his exploration of psychedelic interventions for DoC (2025), GABA dynamics in motor cortex function (2025), ketamine-induced consciousness changes (2025), and validation of diagnostic tools like BERA (2025). His studies span neuroimaging, pharmacology, and clinical neuroscience, with a strong emphasis on translational research.
Methodological Expertise: Cardone utilizes cutting-edge technologies including 7 Tesla MRI, connectome harmonic decomposition, and effective connectivity analysis to map neural activity and pharmacologically induced brain reorganization. His work bridges empirical studies with computational modeling, particularly in virtual clinical trials (2024).
